Jefferies Downgrades Rohto Pharmaceutical to Underperform From Buy, Adjusts Price Target to 2,450 Yen From 3,900 Yen

杰富瑞将罗hto药品评级从买入下调至表现不佳，将目标价从3900日元调整至2450日元。

MT Newswires · 2024/11/19 22:54 · 评级/大行评级

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登录免费看全文

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Jefferies Downgrades Rohto Pharmaceutical to Underperform From Buy, Adjusts Price Target to 2,450 Yen From 3,900 Yen

Jefferies Downgrades Rohto Pharmaceutical to Underperform From Buy, Adjusts Price Target to 2,450 Yen From 3,900 Yen

热门市场机会

热门讨论

热门讨论

Jefferies Downgrades Rohto Pharmaceutical to Underperform From Buy, Adjusts Price Target to 2,450 Yen From 3,900 Yen

Jefferies Downgrades Rohto Pharmaceutical to Underperform From Buy, Adjusts Price Target to 2,450 Yen From 3,900 Yen

风险及免责提示

热门市场机会

热门讨论

热门讨论

声明